rs535350857
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_000719.7(CACNA1C):c.5600G>A(p.Arg1867Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,613,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 missense
NM_000719.7 missense
Scores
4
12
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1C. . Gene score misZ 6.4654 (greater than the threshold 3.09). Trascript score misZ 7.2674 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
BP4
Computational evidence support a benign effect (MetaRNN=0.13743314).
BP6
Variant 12-2685762-G-A is Benign according to our data. Variant chr12-2685762-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 518667.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS2
High AC in GnomAdExome4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5939G>A | p.Arg1980Gln | missense_variant | 47/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.5813G>A | p.Arg1938Gln | missense_variant | 45/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.5780G>A | p.Arg1927Gln | missense_variant | 44/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5765G>A | p.Arg1922Gln | missense_variant | 45/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5744G>A | p.Arg1915Gln | missense_variant | 46/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5723G>A | p.Arg1908Gln | missense_variant | 44/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.5705G>A | p.Arg1902Gln | missense_variant | 45/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.5705G>A | p.Arg1902Gln | missense_variant | 45/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5690G>A | p.Arg1897Gln | missense_variant | 44/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5690G>A | p.Arg1897Gln | missense_variant | 44/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5690G>A | p.Arg1897Gln | missense_variant | 44/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5690G>A | p.Arg1897Gln | missense_variant | 44/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5684G>A | p.Arg1895Gln | missense_variant | 45/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5675G>A | p.Arg1892Gln | missense_variant | 45/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5660G>A | p.Arg1887Gln | missense_variant | 45/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5657G>A | p.Arg1886Gln | missense_variant | 44/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5657G>A | p.Arg1886Gln | missense_variant | 44/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5657G>A | p.Arg1886Gln | missense_variant | 44/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.5651G>A | p.Arg1884Gln | missense_variant | 44/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.5642G>A | p.Arg1881Gln | missense_variant | 44/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.5624G>A | p.Arg1875Gln | missense_variant | 43/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.5624G>A | p.Arg1875Gln | missense_variant | 43/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.5618G>A | p.Arg1873Gln | missense_variant | 43/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.5600G>A | p.Arg1867Gln | missense_variant | 44/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.5591G>A | p.Arg1864Gln | missense_variant | 44/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.5567G>A | p.Arg1856Gln | missense_variant | 43/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152178Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 248922Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135052
GnomAD3 exomes
AF:
AC:
2
AN:
248922
Hom.:
AF XY:
AC XY:
1
AN XY:
135052
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461422Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727000
GnomAD4 exome
AF:
AC:
17
AN:
1461422
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74458
GnomAD4 genome
AF:
AC:
2
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1867 of the CACNA1C protein (p.Arg1867Gln). This variant is present in population databases (rs535350857, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of long QT syndrome (Invitae). ClinVar contains an entry for this variant (Variation ID: 518667). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1C protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2023 | The p.R1867Q variant (also known as c.5600G>A), located in coding exon 44 of the CACNA1C gene, results from a G to A substitution at nucleotide position 5600. The arginine at codon 1867 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of Timothy syndrome or long QT syndrome; however, its contribution to the development of CACNA1C-related neurodevelopmental disorder is uncertain. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | CACNA1C: BP4 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL
Benign
Sift
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.95, 0.062, 0.93, 0.33, 0.96, 0.97, 0.80, 0.65, 0.98, 0.89, 1.0, 0.88
.;P;B;P;B;D;D;D;P;P;P;D;P;D;D;.;D;D;.;.;.;P;.
Vest4
MVP
MPC
0.43
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at